NCPDP Foundation Funds New Project to Streamline REMS Process for the Industry [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
Supported with a NCPDP Foundation grant, the project will rely on the REMS transaction within the NCPDP SCRIPT standard. It aims to show how the standard can significantly enhance patient safety and ease administrative burdens by reducing manual processing delays. SCOTTSDALE, Ariz. April 19, 2024 /PRNewswire-PRWeb/ -- Getting specialty medications into the hands of those who need them quickly and safely is the goal of the latest project to receive funding from the NCPDP Foundation. InfoWerks —a leading provider of healthcare data management solutions—will spearhead the project, which aims to streamline data exchange for the FDA's Risk Evaluation and Mitigation Strategy (REMS) plan. The use of the NCPDP SCRIPT standard in this project will ensure data is accurate, consistent, and secure, which is fundamental to patient safety when dealing with high-risk medications and emerging therapies. The REMS plan, created by the FDA, aims to ensure the benefits for patients outweigh the ris
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the FirmAccesswire
- Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)Business Wire
- Investors who lost money on GoodRx Holdings, Inc.(GDRX) should contact Levi & Korsinsky about pending Class Action - GDRXAccesswire
- Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for Investors - Contact Levi & KorsinskyAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against GoodRx Holdings, Inc. - GDRXGlobeNewswire
GDRX
Earnings
- 2/29/24 - Beat
GDRX
Sec Filings
- 5/2/24 - Form SC
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- GDRX's page on the SEC website